American Urological Association - Doppler and Advanced Techniques in Urologic Ultrasound CME Instructions

advertisement

Home Education AUAUniversity Online Learning Webcasts Doppler and Advanced Techniques in Urologic Ultrasound CME Instructions

Doppler and Advanced Techniques in Urologic Ultrasound CME Instructions

Overview/Statement of Need

The advanced urologic ultrasound video is designed for participants who have a basic understanding of the physics of ultrasound and some experience with clinical scanning. This film teaches the physics of Doppler ultrasound and how to use physical principles to improve image quality and understand ultrasound artifacts. It is important for those urologists seeking to improve their ultrasound expertise in the operating room and in the office.

These videos satisfy the AIUM requirement – “The physician should complete 10 hours of AMA PRA Category 1 Credits™ specific to genitourinary ultrasound every 3 years.”

Learning Objectives

At the conclusion of this video, participants should be able to:

  • Identify the clinical indications for the performance color, power and/or spectral Doppler ultrasound.
  • Describe the steps for calculating resistive indices and interpreting the results.
  • State the principles associated with ALARA for the use of ultrasound.

Accreditation

The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

The American Urological Association designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. The AUA takes responsibility for the content, quality, and scientific integrity of this CME activity.

Estimated Time to Complete Activity

1 hour

Target Audience

Urologists, Urology Residents

Media Used

Online

Method of Physician Participation and Instructions on Claiming Credits

To claim credits/hours of participation, participants must take the online pretest, view the online video, take the online posttest passing with a score of at least 80%, complete and submit the evaluation.

AUA Disclosure Policy

All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) participating in an educational activity provided by the AUA are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

Evidence Based Content

It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

Resolution of Identified Conflict of Interest

All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

  • Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or Education Content Review Committee or its subgroup.
  • Limit content to evidence with no recommendations
  • Introduction of a debate format with an unbiased moderator (point-counterpoint)
  • Inclusion of moderated panel discussion
  • Publication of a parallel or rebuttal article for an article that is felt to be biased
  • Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
  • Divestiture of the relationship by faculty

Faculty

The content of this enduring material was developed by Jaime Landman, MD.

Faculty Disclosures

Pat Fox Fulgham, MD
Disclosures: Urology Clinics of North Texas: Investment Interest

Planners

Planning Committee Members’ Disclosures

Urologic Diagnostic & Therapeutic Imaging Committee (UDTIC)

Ronney Abaza, MD
Disclosures: Intuitive Surgical Inc: Other; Surgiquest Inc.: Scientific Study or Trial; Ohio Urological Society: Leadership Position

Dean G. Assimos, MD
Disclosures: Oxalosis and Hyperoxaluria Foundation (OHF): Consultant or Advisor; Medical Review in Urology: Health Publishing; Urology Times: Health Publishing; National Institute of Health (NIH): IScientific Study or Trial

Patrick N. Ciccone, MD
Disclosures: Nothing to disclose

Frederick A. Gulmi, MD
Disclosures: Brooklyn Urologic Research Group: Leadership Position; Allied Urological Services and Metropolitan Lithotripsy Associates: Leadership Position, Investment Interest, Employee; CHD Biosciences: Consultant or Advisor

Blake D. Hamilton, MD
Disclosures: MextMed, Inc.: Consultant or Advisor; Karl Storz Endoscopy: Meeting Participant or Lecturer; Cook Urological: Consultant or Advisor

Peter M. Knapp Jr., MD
Disclosures: Medtronic: Scientific Study or Trial, Other; Strand Diagnostics LLC: Consultant or Advisor, Owner, Product Development

Tracey Lynn Krupski, MD
Disclosure: Nothing to disclose

Jaime Landman, MD
Cook Urological: Consultant or Advisor, Owner, Product Development; Cook: Consultant or Advisor; Galil Medical: Consultant or Advisor, Scientific Study or Trial

Surena F. Matin, MD
Disclosures: Mike Hogg Fund: Scientific Study or Trial; AT&T: Scientific Study or Trial

Elspeth McDougall, MD
Disclosure: Nothing to disclose

Arturo Mendoza-Valdes, MD
Disclosures: Bristol Myers: Scientific Study or Trial; AMGEN: Consultant or Advisor, Meeting Participant or Levturer; TEVA: Consultant or Advisor, Meeting Participant or Levturer; BAYER: Consultant or Advisor, Meeting Participant or Levturer

David F. Penson, MD
Disclosures: Patient-Centered Outcomes Research Institute: Scientific Study or Trial; Astellas: Scientific Study or Trial; medivation: Scientific Study or Trial; National Institutes of Health: Consultant or Advisor; US Agency for Healthcare Research and Quality: Consultant or Advisor, Scientific Study or Trial

Christopher Porter, MD
Disclosures: Nothing to disclose

Daniel Rukstalis, MD
Disclosures: Nothing to disclose

Sheila Stark, PhD
Disclosures: Nothing to disclose

Stephanie Stinchcomb, CPC
Disclosures: Accurate Coding Solutions: Consultant or Advisor; Board of Medical Specialty Coding: Consultant or Advisor

Martha K. Terris, MD
Disclosures: Nothing to disclose

J. Brantley Thrasher, MD
Disclosures: Oakstone Publishing's Practical Reviews in Urology: Leadership Position; Urology Times: Leadership Position; Residency Review Committee in Urology: Leadership Position; Society of Urologic Oncology: Leadership Position; SUCPD: Leadership Position

Edouard J. Trabulsi, MD
Disclosures: Centocor: Consultant or Advisor, Meeting Participant or Lecturer; Dendronl: Consultant or Advisor, Meeting Participant or Lecturer; Medivation: Consultant or Advisor, Meeting Participant or Lecturer; Photocure: Consultant or Advisor

Date of Original Release

December, 2014

Review Date

This activity was peer reviewed on December, 2014.

Expiration Date

November, 2017

Off-label or Unapproved Use of Drugs or Devices

It is the policy of the AUA to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

Disclaimer

The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.

Consent to Use of Photographic Images

Registration and attendance at or participation in AUA meetings and other activities constitutes an agreement by the registrant to AUA's use and distribution (both now and in the future) of the registrant or attendee's image or voice in photographs, videotapes, electronic reproductions, and audiotapes of such events and activities.

Audio, Video and Photographic Equipment

The use of audio, video and other photographic recording equipment by attendees is prohibited inside AUA meeting rooms.

Reproduction Permission

Reproduction of written materials developed for this AUA course is prohibited without the written permission from individual authors and the American Urological Association.

AUA Privacy and Confidentiality Policy

www.auanet.org/education/confidentiality-statement.cfm

Copyright

Materials contained within this DVD are the sole property of the American Urological Association, Inc. and may not be copied or duplicated without the written permission of the American Urological Association, Inc.

© 2014 American Urological Association, Inc.® All Rights Reserved

Contact Information

American Urological Association
Office of Education
1000 Corporate Blvd
Linthicum, MD 21090
Toll Free (U.S. only): 1-866-RING AUA (1-866-746-4282)
Phone: 410-689-3700
Fax: 410-689-3800

Advertisement

Advertisement